全身低温与目标体温正常对轻度脑病新生儿的比较:一项多中心先导随机临床试验
这项开放标签、三臂先导随机临床试验于2019年10月31日至2023年4月28日在英国和意大利6个三级新生儿重症监护病房开展,纳入胎龄≥36周、有严重出生酸中毒、需持续复苏或出生后10分钟Apgar评分<6分且改良Sarnat分期显示轻度缺氧缺血性脑病的新生儿101例。按年龄随机分为体温正常组(n=34)、48小时低温组(n=31)和72小时低温组(n=36),主要终点为出生后4至7天丘脑N-乙酰天冬氨酸浓度。结果显示,与体温正常组10.98 mmol/kg湿重相比,48小时低温组为8.36 mmol/kg湿重(平均差-2.62,95%CI -3.34至-1.89),72小时低温组为9.02 mmol/kg湿重(平均差-1.96,95%CI -2.66至-1.26),低温未改善脑磁共振生物标志物,且低温组基线病情更重。作者认为全身低温的安全性和有效性需在随机临床试验中评估。
要点
- 在轻度缺氧缺血性脑病新生儿中,48小时低温组丘脑N-乙酰天冬氨酸为8.36 mmol/kg湿重,低于体温正常组的10.98 mmol/kg湿重(平均差-2.62,95%CI -3.34至-1.89)。
- 72小时低温组丘脑N-乙酰天冬氨酸为9.02 mmol/kg湿重,低于体温正常组的10.98 mmol/kg湿重(平均差-1.96,95%CI -2.66至-1.26)。
- 48小时低温组出生时需插管比例为14/31(45.2%),72小时低温组为13/36(36.1%),均高于体温正常组的3/34(8.8%),提示低温组基线病情更重。
- 出生6小时后癫痫发作在体温正常组为1例(2.9%)、48小时低温组1例(3.2%)、72小时低温组2例(5.6%)。
- 常规磁共振生物标志物损伤评分在各组间相似,99例(98.0%)有磁共振数据,87例(86.1%)有N-乙酰天冬氨酸数据。
适用人群与场景
- 胎龄≥36周、有严重出生酸中毒、需持续复苏或出生后10分钟Apgar评分<6分,且改良Sarnat分期显示轻度缺氧缺血性脑病的新生儿。
- 在英国和意大利6个三级新生儿重症监护病房住院的新生儿。
- 随机分组时不足6小时者随机至体温正常或72小时低温(33.5 °C);6小时及以上且已接受全身低温者随机至48小时或72小时低温后复温。
诊断标准与关键阈值
- 轻度缺氧缺血性脑病依据改良Sarnat分期判定。
- 出生后10分钟Apgar评分<6分作为纳入条件之一。
- 严重出生酸中毒或需持续复苏作为纳入条件之一。
处置流程与药物剂量
- 随机分组基于年龄:不足6小时者随机至体温正常或72小时低温(33.5 °C)。
- 6小时及以上且已接受全身低温者随机至48小时或72小时低温后复温。
红旗征与不能漏的情况
- 出生6小时后发生癫痫发作:体温正常组1例(2.9%)、48小时低温组1例(3.2%)、72小时低温组2例(5.6%)。
研究设计与关键结果
- 开放标签、三臂先导随机临床试验,2019年10月31日至2023年4月28日,6个三级新生儿重症监护病房,纳入101例(男性54例[53.5%]),48例(47.5%)随机时不足6小时,53例(52.5%)6小时及以上。
- 体温正常组(n=34)平均(标准差)胎龄39.5(1.1)周、出生体重3378(380)克;48小时低温组(n=31)为38.7(0.5)周、3017(338)克;72小时低温组(n=36)为39.0(1.1)周、3293(252)克。
- 主要终点丘脑N-乙酰天冬氨酸浓度:体温正常组10.98(0.92)mmol/kg湿重 vs 48小时低温组8.36(1.23)mmol/kg湿重(平均差-2.62,95%CI -3.34至-1.89)vs 72小时低温组9.02(1.79)mmol/kg湿重(平均差-1.96,95%CI -2.66至-1.26)。
- 常规磁共振生物标志物损伤评分在各组间相似;99例(98.0%)有磁共振数据,87例(86.1%)有N-乙酰天冬氨酸数据。
- 出生时需插管:48小时低温组14/31(45.2%)、72小时低温组13/36(36.1%)、体温正常组3/34(8.8%)。
- 出生6小时后癫痫发作:体温正常组1例(2.9%)、48小时低温组1例(3.2%)、72小时低温组2例(5.6%)。
证据类型、等级与局限
- 研究类型:开放标签、三臂先导随机临床试验,盲法结局分析,按意向治疗分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在这项先导随机临床试验中,全身低温未改善轻度缺氧缺血性脑病后的脑磁共振生物标志物,尽管低温组新生儿基线病情更重。
- 作者认为,全身低温的安全性和有效性应在随机临床试验中评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Although whole-body hypothermia is widely used after mild neonatal hypoxic-ischemic encephalopathy (HIE), safety and efficacy have not been evaluated in randomized clinical trials (RCTs), to our knowledge.
OBJECTIVE: To examine the effect of 48 and 72 hours of whole-body hypothermia after mild HIE on cerebral magnetic resonance (MR) biomarkers.
DESIGN, SETTING, AND PARTICIPANTS: This open-label, 3-arm RCT was conducted between October 31, 2019, and April 28, 2023, with masked outcome analysis. Participants were neonates at 6 tertiary neonatal intensive care units in the UK and Italy born at or after 36 weeks' gestation with severe birth acidosis, requiring continued resuscitation, or with an Apgar score less than 6 at 10 minutes after birth and with evidence of mild HIE on modified Sarnat staging. Statistical analysis was per intention to treat.
INTERVENTIONS: Random allocation to 1 of 3 groups (1:1:1) based on age: neonates younger than 6 hours were randomized to normothermia or 72-hour hypothermia (33.5 °C), and those 6 hours or older and already receiving whole-body hypothermia were randomized to rewarming after 48 or 72 hours of hypothermia.
MAIN OUTCOMES AND MEASURES: Thalamic N-acetyl aspartate (NAA) concentration (mmol/kg wet weight), assessed by cerebral MR imaging and thalamic spectroscopy between 4 and 7 days after birth using harmonized sequences.
RESULTS: Of 225 eligible neonates, 101 were recruited (54 males [53.5%]); 48 (47.5%) were younger than 6 hours and 53 (52.5%) were 6 hours or older at randomization. Mean (SD) gestational age and birth weight were 39.5 (1.1) weeks and 3378 (380) grams in the normothermia group (n = 34), 38.7 (0.5) weeks and 3017 (338) grams in the 48-hour hypothermia group (n = 31), and 39.0 (1.1) weeks and 3293 (252) grams in the 72-hour hypothermia group (n = 36). More neonates in the 48-hour (14 of 31 [45.2%]) and 72-hour (13 of 36 [36.1%]) groups required intubation at birth than in the normothermic group (3 of 34 [8.8%]). Ninety-nine neonates (98.0%) had MR imaging data and 87 (86.1%), NAA data. Injury scores on conventional MR biomarkers were similar across groups. The mean (SD) NAA level in the normothermia group was 10.98 (0.92) mmol/kg wet weight vs 8.36 (1.23) mmol/kg wet weight (mean difference [MD], -2.62 [95% CI, -3.34 to -1.89] mmol/kg wet weight) in the 48-hour and 9.02 (1.79) mmol/kg wet weight (MD, -1.96 [95% CI, -2.66 to -1.26] mmol/kg wet weight) in the 72-hour hypothermia group. Seizures occurred beyond 6 hours after birth in 4 neonates: 1 (2.9%) in the normothermia group, 1 (3.2%) in the 48-hour hypothermia group, and 2 (5.6%) in the 72-hour hypothermia group.
CONCLUSIONS AND RELEVANCE: In this pilot RCT, whole-body hypothermia did not improve cerebral MR biomarkers after mild HIE, although neonates in the hypothermia groups were sicker at baseline. Safety and efficacy of whole-body hypothermia should be evaluated in RCTs.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03409770.
参考来源
- Montaldo P, Cirillo M, Burgod C, et al. Whole-Body Hypothermia vs Targeted Normothermia for Neonates With Mild Encephalopathy: A Multicenter Pilot Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 38709535. doi:10.1001/jamanetworkopen.2024.9119
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。